Article Text
Structured abstracts of sentinel articles: Picket
Drug-free inactive disease in juvenile idiopathic arthritis can be achieved for 40% of patients
Statistics from Altmetric.com
Study design: randomised, single-blind trial.
Study question
Setting: The Netherlands.1
Patients: 94 patients with new-onset (symptom duration <18 months) juvenile idiopathic arthritis (JIA) who had not been exposed to previous disease-modifying antirheumatic drug (DMARD) therapy.
Interventions: conventional systemic DMARD monotherapy (methotrexate (MTX) or sulfasalazine) versus MTX plus 6-week tapered course of prednisolone vs MTX plus etarnercept.
Outcomes: time to inactive disease; time to flare after the first episode of drug-free inactive disease (DFID).
Main results: …
Footnotes
Contributors LC: wrote the abstract. AJF and LC: jointly wrote the commentary.
Provenance and peer review Not commissioned; internally peer reviewed.